| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |